The medial temporal cortex (MTC) has been implicated in the pathogenesis of pediatric major depressive disorder (MDD). Eleven MDD case-control pairs underwent proton magnetic resonance spectroscopic imaging. N-acetyl-aspartate was lower in the left MTC (27%) in MDD patients versus controls. Lower N-acetyl-aspartate concentrations in MDD patients may reflect reduced neuronal viability.
Introduction
Current models of major depressive disorder (MDD) propose that neuronal dysfunction, loss, or damage in the hippocampus is a hallmark of the disease (Sapolsky, 2000) . Consistent with reports in adults with MDD (Sheline et al., 1999; MacQueen et al., 2003) , smaller hippocampal volumes have been noted in pediatric MDD (MacMaster and Kusumakar, 2004; MacMaster et al., 2008) , although conflicting reports do exist (Rosso et al., 2005) . The aim of this study is to determine if hippocampal neuronal viability, as represented by medial temporal cortex (MTC) N-acetyl-aspartate (NAA) concentrations, is impaired in pediatric treatment-naïve MDD as compared with healthy control children. Studies of pediatric MDD patients minimize potential confounds such as treatment intervention and illness duration; and they may clarify potential neurodevelopmental abnormalities related to the pathogenesis of the disease.
Methods

Sample
Eleven treatment-naïve pediatric outpatients with MDD (10-16 years of age) and 11 healthy subjects were case-control matched for age, gender, weight, height, parental socioeconomic status and handedness. The Kiddie Schedule for Affective Disorders and Schizophrenia (Kaufman et al., 1997) 
